GNH USA

Europe — EMA

Noradrenalin Sintetica (Noradrenaline Tartrate)

GNH USA supplies Noradrenalin Sintetica (Noradrenaline Tartrate), a vasopressor for hypotension, septic shock and cardiac arrest.

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline tartrate, the active ingredient in Noradrenalin Sintetica, is a sympathomimetic agent presented as an injectable solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in acute circulatory failure such as hypotension, septic shock and cardiac arrest. GNH USA supplies Noradrenalin Sintetica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Noradrenaline Tartrate used for?

Noradrenalin Sintetica is a vasopressor that acts on the sympathetic cardiovascular pathway to restore adequate perfusion. - Hypotension: raises systemic vascular resistance to increase arterial pressure. - Septic shock: counteracts profound vasodilation and supports organ perfusion. - Cardiac arrest: enhances coronary and cerebral blood flow during resuscitation efforts.

What are the side effects of Noradrenaline Tartrate?

Adverse reactions may occur with intravenous administration of Noradrenalin Sintetica.

Common Side Effects: - Headache: transient, often related to rapid blood pressure changes. - Tachycardia: increased heart rate due to beta‑1 stimulation. - Palpitation: awareness of heartbeats during infusion. - Nausea: mild gastrointestinal discomfort. - Peripheral ischemia: reduced blood flow to extremities.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening rhythm disturbances. - Myocardial ischemia: chest pain or infarction from excessive vasoconstriction. - Severe hypertension: abrupt, dangerous rise in blood pressure. - Tissue necrosis: extravasation at the infusion site. - Pulmonary edema: fluid accumulation in lungs due to cardiac overload.

What precautions apply to Noradrenaline Tartrate?

Noradrenalin Sintetica requires careful monitoring and specific safety measures. - Cardiac monitoring: continuous ECG to detect arrhythmias. - Blood pressure monitoring: frequent measurements to avoid overshoot hypertension. - Dose titration: adjust infusion rate based on hemodynamic response. - Extravasation risk: use central venous access when possible. - Contraindications: avoid in patients with uncorrected pheochromocytoma. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenalin Sintetica can interact with other agents that affect cardiovascular tone.

Major Interactions (Avoid): - Beta‑blockers: may blunt desired increase in cardiac output. - MAO inhibitors: can potentiate hypertensive response. - Tricyclic antidepressants: increase risk of severe hypertension.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: additive vasodilatory effects may require dose adjustment. - Diuretics: may exacerbate hypovolemia, influencing response. - Inhaled anesthetics: can alter vascular reactivity during surgery.

Frequently asked questions

What conditions is Noradrenalin Sintetica used for?+
Noradrenalin Sintetica is indicated for the acute management of severe hypotension, septic shock, and cardiac arrest. In these critical situations it helps raise blood pressure and improve organ perfusion by stimulating vascular and cardiac receptors.
How does noradrenaline tartrate work in the body?+
Noradrenaline tartrate acts as a direct agonist at alpha‑adrenergic receptors, causing vasoconstriction and increasing systemic vascular resistance. It also stimulates beta‑1 receptors in the heart, enhancing contractility and cardiac output, which together support blood pressure and tissue perfusion.
What is the usual dose of Noradrenalin Sintetica?+
The dosage of Noradrenalin Sintetica is individualized and set by the prescribing clinician based on the patient’s hemodynamic status, response to therapy, and clinical guidelines. Dosing is typically administered as an intravenous infusion that is titrated to effect.
Is Noradrenalin Sintetica safe during pregnancy or breastfeeding?+
The safety of Noradrenalin Sintetica in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.
How do I order Noradrenalin Sintetica from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.
How does Noradrenalin Sintetica compare with other vasopressors?+
Noradrenalin Sintetica is a first‑line vasopressor because of its strong alpha‑adrenergic activity combined with modest beta‑1 stimulation. Compared with agents such as dopamine or phenylephrine, it provides more predictable increases in blood pressure with less tachyarrhythmia risk, making it preferred in many critical‑care protocols.
What are the storage requirements for Noradrenalin Sintetica?+
The product should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep it in the original packaging to maintain stability until it is prepared for intravenous administration.
How is Noradrenalin Sintetica administered?+
Noradrenalin Sintetica is supplied as an injectable solution for intravenous infusion. It is typically administered through a central venous catheter, with the infusion rate adjusted continuously based on the patient’s blood pressure and cardiac response.
What are the most serious risks associated with Noradrenalin Sintetica?+
Serious risks include severe hypertension, life‑threatening arrhythmias, myocardial ischemia, tissue necrosis from extravasation, and pulmonary edema. Continuous hemodynamic monitoring is essential to detect and manage these complications promptly.
Who should not receive Noradrenalin Sintetica?+
Patients with known hypersensitivity to noradrenaline or its excipients, uncorrected pheochromocytoma, or those in whom severe vasoconstriction could cause harm (e.g., certain peripheral vascular diseases) should not receive this medication. Clinical judgment is required for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Sintetica Gmbh
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU